AA
IRON icon

ALPS Advisors’s Disc Medicine IRON Stock Holding History

ALPS Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Buy
38,565
+7,507
+24% +$516K 0.01% 421
2026
Q1 		$1.99M Buy
31,058
+56
+0.2% +$3.89K 0.01% 404
2025
Q4 		$2.46M Buy
31,002
+14,210
+85% +$1.2M 0.01% 361
2025
Q3 		$1.11M Sell
16,792
-1,834
-10% -$109K 0.01% 494
2025
Q2 		$986K Sell
18,626
-6,853
-27% -$322K 0.01% 504
2025
Q1 		$1.26M Buy
25,479
+1,412
+6% +$78.5K 0.01% 422
2024
Q4 		$1.53M Buy
24,067
+1,179
+5% +$68.2K 0.01% 387
2024
Q3 		$1.12M Buy
22,888
+3,586
+19% +$168K 0.01% 468
2024
Q2 		$870K Buy
19,302
+2,272
+13% +$77.2K 0.01% 497
2024
Q1 		$1.06M Buy
17,030
+880
+5% +$57.1K 0.01% 464
2023
Q4 		$933K Sell
16,150
-750
-4% -$38.4K 0.01% 498
2023
Q3 		$794K Buy
16,900
+2,346
+16% +$117K 0.01% 521
2023
Q2 		$646K Buy
+14,554
New +$516K 0.01% 566
2021
Q4 		– Sell
-1,761
Closed -$213K – 929
2021
Q3 		$213K Sell
1,761
-129
-7% -$17.6K ﹤0.01% 896
2021
Q2 		$367K Buy
+1,890
New +$621K ﹤0.01% 637

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ALPS Advisors's IRON Position: Q2 2026 in Review

ALPS Advisors increased its Disc Medicine (IRON) stake by 24% in Q2 2026, buying an estimated $516K and bringing the position to 38,565 shares worth $2.82M. The position accounts for 0.01% of the portfolio, ranked #421.

ALPS Advisors first reported a position in IRON in Q2 2021 and has held it in 15 quarters since. 217 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • ALPS Advisors held 38,565 shares of Disc Medicine worth $2.82M as of Q2 2026.
  • ALPS Advisors bought 7,507 Disc Medicine shares in Q2 2026, an estimated $516K.
  • Disc Medicine made up 0.01% of ALPS Advisors's portfolio in Q2 2026, its #421 holding.
  • ALPS Advisors first reported a position in Disc Medicine in Q2 2021 and has held it in 15 quarters since.
  • 217 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.